search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
CARE HOMES


WITH INCREASING NUMBERS OF FRAILER, OLDER PEOPLE LIVING WITH LONG-TERM CONDITIONS AND INCREASINGLY COMPLEX REQUIREMENTS, PHARMACEUTICAL CARE OF PEOPLE IN CARE HOMES IS INCREASINGLY COMING UNDER THE SPOTLIGHT.


BRINGING


Surrey, found that medication errors in prescribing, monitoring, dispensing and administering medicines, were common.


PHARMACEUTICAL CARE ‘HOME’ I


n 2013, the Care Home Use of Medicines Study (CHUMS), which was carried out by the University of


The CHUMS report was referenced in the Royal Pharmaceutical Society’s (RPS) 2012 ‘Improving Pharmaceutical Care in Care Homes’ report, which specifi ed that the provision of


18 - SCOTTISH PHARMACIST


pharmaceutical care in Scottish care homes was in need of a ‘radical examination’. Recommendations included the need for ‘a more robust contract system and service level agreement’ between community pharmacy services and care home providers to enable safe and effective change.


For the CHUMS report, researchers visited homes, talked to the staff, reviewed the medication of selected


residents, observed medicines being given, and made observations in the home. They also visited the surgeries of the residents’ GPs and reviewed records, as well as some pharmacies.


Two hundred and 56 elderly residents, who lived in 55 residential and nursing care homes, were considered, and researchers found that the majority of care homes were serviced by one pharmacy.


Seven out of ten residents were exposed to at least one medication error (69.5 per cent) and the odds of a person in residential care receiving a medication error was 1.31 times greater than one receiving nursing care.


The prevalence of errors was: prescribing (8.3 per cent); monitoring (14.7 per cent) (for relevant medicines); dispensing (9.8 per cent), and administration (8.4 per cent).


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48